Scenarios that move BLCO
Bausch + Lomb Corporation Common Shares
Scenarios that move BLCO: 3 analyses, 1 positive, 2 negative.
- · Opus Genetics receives FDA approval for presbyopia eye drop — ▼ · impact -25 · confidence medium · horizon weeks
- · Roche reports positive Phase III eye drug data, FDA accepts BLA — ▼ · impact -24 · confidence low · horizon quarters
- · Cooper Companies faces scrutiny as US channel inventories decline — ▲ · impact +40 · confidence low · horizon weeks